NCT02408484View on ClinicalTrials.gov

Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

June 11, 2019

Study Completion Date

June 11, 2019

Conditions
Congenital Fibrinogen Deficiency
Interventions
BIOLOGICAL

Octafibrin

Plasma-derived Fibrinogen concentrate

Trial Locations (4)

560034

St. John's Medical College Hospital, Bangalore

577005

S.S Institute of Medical Science and Research Center, Davangere

Unknown

Nemazee Hospital Shiraz University of Medical Sciences, Shiraz

Hotel De Dieu de France, Beirut

Sponsors

Lead Sponsor

Octapharma
All Listed Sponsors
lead

Octapharma

INDUSTRY